Corporate News     20-May-23 Board of Dilip Buildcon recommends Final Dividend Of Rs.0.1 per share Dilip Buildcon announced that the Board of Directors of the Company at its meeting held on 19 May 2023, has recommended a Final dividend of Rs.0.1 per share (i.e.1%), subject to the approval of the shareholders. Previous News   Dilip Buildcon jumps after board nod to offload stakes in SPVs  ( Hot Pursuit - 09-Jun-25   15:15 )   Dilip Buildcon consolidated net profit rises 242.77% in the September 2024 quarter  ( Results - Announcements 14-Nov-24   10:25 )   Dilip Buildcon consolidated net profit rises 842.35% in the June 2024 quarter  ( Results - Announcements 13-Aug-24   13:49 )   Dilip Buildcon slips after Q1 PAT slides 76% YoY in FY25  ( Hot Pursuit - 13-Aug-24   14:58 )   Reliance Infrastructure Ltd leads gainers in 'A' group  ( Hot Pursuit - 14-Feb-24   12:00 )   Dilip Buildcon gains on recording multi-fold jump in Q2 PAT  ( Hot Pursuit - 14-Nov-24   10:25 )   Dilip Buildcon rises as JV bags LoA for Rs 413-cr project in MP  ( Hot Pursuit - 18-Mar-24   15:57 )   Dilip Buildcon to conduct board meeting  ( Corporate News - 05-Jul-23   10:27 )   Dilip Buildcon gains on receiving LoAs from NHAI  ( Hot Pursuit - 19-Dec-22   10:40 )   Dilip Buildcon AGM scheduled  ( Corporate News - 09-Aug-23   10:14 )   Dilip Buildcon corsotium bags BharatNet project of Rs 1625.36 cr  ( Corporate News - 12-Nov-24   15:54 )	Other Stories   Board of HCL Technologies recommends Interim Dividend   14-Jul-25   17:52   Objectone Information Systems to conduct board meeting   14-Jul-25   17:50   JTEKT India AGM scheduled   14-Jul-25   17:50   Setco Automotive to discuss results   14-Jul-25   17:50   Saurashtra Cement to hold board meeting   14-Jul-25   17:49   John Cockerill India to table results   14-Jul-25   17:49   ATV Projects India to conduct board meeting   14-Jul-25   17:49   Shilchar Technologies schedules AGM   14-Jul-25   17:49   Sun Pharma settles litigation related to LEQSELVI™ with Incyte   14-Jul-25   16:53   Sun Pharmaceutical Industries launches LEQSELVI™ (deuruxolitinib) 8 mg tablets in United States   14-Jul-25   16:48
Back Top